SEMICARBAZONE COMPOUNDS, COMPOSITION Russian patent published in 2001 - IPC

Abstract RU 2174115 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes compounds of semi-carbazone of the formula (I) where R1,R2,R3,R4 can be similar or different and mean halogen atom, C1-9-alkyl, cyano-group, C1-9-alkoxy-group or phenoxy-group; R5 means hydrogen atom or C1-9-alkyl; X means oxygen or sulfur atom under condition that: a) if X is sulfur atom then at least one of radicals R1 and R2 is not hydrogen atom but other substitute or at least one of radicals R3 and R4 is fluorine atom, C1-9-alkyl, cyano-group, C1-9-alkoxy-group; b) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and one of radicals R1 and R2 is chlorine atom then other radical of R1 and R2 is not hydrogen or chlorine atom or at least one radical of R3 and R4 is not hydrogen atom but other substitute; c) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and one of radicals R1 and R2 is methoxy-group then other radical of R1 and R2 is not hydrogen atom or methoxy-group or at least one radical of R3 and R4 is not hydrogen atom and other is a substitute; d) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and one of radicals R1 and R2 is methyl then other radical of R1 and R2 is not hydrogen atom or at least one radical of R3 and R4 is not hydrogen atom but other substitute and e) if X means oxygen atom, R5 means hydrogen atom, methyl or ethyl and if both radicals R1 and R2 mean hydrogen atom then at least one radical of R3 and R4 is not hydrogen atom and methyl but other substitute, or their pharmaceutically acceptable salt. Compounds can be administrated orally for treatment of animals with convulsions. EFFECT: valuable pharmacological properties of compounds. 14 cl, 6 tbl, 3 dwg, 2 ex

Similar patents RU2174115C2

Title Year Author Number
2-PROPYL-2-PENTANIC OR 2-PROPYL-2-PENTENIC ACID AMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION BASED THEREON 1994
  • Mejr Bialer
  • Salim Khadad
  • Jakob Kherzig
  • Dzheff Sterling
  • Dehvid Lerner
  • Mitchell Shirvan
RU2140904C1
SUBSTITUTED TRIA-AZOLES AND METHODS RELATING THERETO 2016
  • Ashweek, Neil, J.
  • Williams, John, P.
  • Slee, Deborah
  • Moorjani, Manisha
RU2718049C2
METHOD OF REALIZATION OF SELECTIVE METHIONINE CELL STARVATION IN MAMMAL BODY, POLYNUCLEOTIDE, CATALYTICALLY ACTIVE POLYPEPTIDE OF RECOMBINANT METHYLTHIOADENOSINE PHOSPHORYLASE 1994
  • Nobori Tsutomu
  • Kason Dennis A.
RU2153885C2
METHOD FOR STRUCTURAL AND/OR FUNCTIONAL IMPROVEMENT OF ARTERIOLES 2005
  • Fogelmehn Ehlan M.
RU2414236C2
DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS 2017
  • Voronina Tatyana Aleksandrovna
  • Kovalev Ivan Georgievich
  • Litvinova Svetlana Aleksandrovna
  • Nerobkova Lyubov Nikolaevna
  • Zhmurenko Lyudmila Aleksandrovna
  • Mokrov Grigorij Vladimirovich
  • Gudasheva Tatyana Aleksandrovna
  • Durnev Andrej Dmitrievich
RU2748419C2
INDIVIDUAL FORMS OF ENANTIOMERS AND THEIR MIXTURES ALSO, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF ELICITING ANTI-CONVULSANT EFFECT 1997
  • Choj Jong Mun
  • Kim Min Vu
  • Park Dzhong Khan
RU2171800C2
ELEUTEROBINS, METHOD FOR KILLING CELLS PRESENT IN CELL POPULATION 1995
  • Dzhensen Pol R.
  • Lindel Tomas
  • Finajkehl Uil'Jam Kh.
RU2146089C1
PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION 2005
  • Anantkharamajakh Gattadakhalli M.
  • Navab Mokhamad
  • Fogelmehn Ehlan M.
RU2448977C2
METHOD OF TREATMENT OF PSORIASIS 1997
  • Shehnk Richard P.
  • Derian Klaudia K.
RU2207854C2
PSEUDOFRUCTOPYRANOSE SULFAMATES AND PHARMACEUTICAL COMPOSITION BASED ON SAID 1994
  • Majkl Dzh. Kostenzo
  • Brjus E.Mar'Janov
  • Dehvid F.Makkomsi
  • Sehmjuel' D.Norti
RU2139875C1

RU 2 174 115 C2

Authors

Dimmok Dzhonatan Richard

P'Juz'Jukoud Ramanan Narajjan

Dates

2001-09-27Published

1996-06-07Filed